![Ventured Growth with Hercules Capital artwork](https://is5-ssl.mzstatic.com/image/thumb/Podcasts115/v4/2e/43/36/2e433624-8ec5-d260-3150-f0f21831eec3/mza_2721947305278181464.jpg/100x100bb.jpg)
#32 - The Future of Drug Affordability and Access | Peter Kolchinsky
Ventured Growth with Hercules Capital
English - June 27, 2024 09:00 - 56 minutes - 78 MB - ★★★★★ - 9 ratingsEntrepreneurship Business Investing venture debt growth capital finance cfo technology life sciences renewable energy ceo investor private equity Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
In an era where breakthrough innovations coexist with concerns over drug affordability, Peter Kolchinsky, founder and Managing Partner at healthcare and life sciences investment manager RA Capital, joins us to shed light on the factors and paths forward.
Hercules Capital's Janice Bourque engages with Peter on his No Patient Left Behind initiative, a non-profit dedicated to making medicines affordable for everyone in America.
Topics Include:
Peter Kolchinsky, PhD is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. Peter is an active investor in and board member of publicly- and privately-held companies developing drugs, medical devices, diagnostics, and research tools. He served on the Board of Global Science and Technology for the National Academy of Sciences, is the author of The Entrepreneur’s Guide to a Biotech Startup, and frequently writes and speaks on the future of biotechnology innovation. Peter founded and serves as a Director of No Patient Left Behind, a non-profit advocate for healthcare reforms that would make today's medicines affordable to patients and promote the innovation that gives all of us hope for tomorrow. He holds a BA from Cornell University and a PhD in Virology from Harvard University.